Iran's atomic chief to go to Vienna for IAEA General Assembly
The head of the Iranian Atomic Organization will go to Vienna to attend the General Assembly of the International Atomic Energy Agency (IAEA), official news agency IRNA reported Saturday.
Gholam-Reza Aqazadeh, who is also vice-president, is scheduled to address the assembly Monday and is also expected to meet with IAEA director general Mohamed ElBaradei, IRNA said.
Aqazadeh is in charge of the technical aspects of Iran's nuclear programmes while Saeid Jalili, as chief nuclear negotiator, is in charge of political talks with the world powers through European Union foreign policy chief Javier Solana.
President Mahmoud Ahmadinejad reiterated at the United Nations in New York that Iran was ready to hold talks with the five permanent members of the UN Security Council plus Germany to settle the dispute over its controversial programmes. But he said Iran would not accept pre-conditions nor give in to demands that is suspend enrichment of uranium.
On Friday the Security Council agreed on a resolution calling on Iran to halt its nuclear activities, but did not seek additional sanctions against the Tehran regime.
- Login or register to post comments
Print
Email to friend
Related Articles
- Tehran terms new draft resolution as "not constructive"
- ElBaradei will not seek another term as IAEA chief
- Iran sends EU new letter over nuclear dispute
- UN nuclear chief inspector arrives in Tehran
- ElBaradei asks for cooperation by Iran, IAEA members
- Iranian, Syrian nuclear intentions in focus as IAEA board meets
- Iran's nuclear chief resigns
- IAEA Board to discuss North Korea, Iran on Wednesday
While, many stories have been written about the many aspects of health-care reform, there are few on how the Americans have reacted and responded...
According to data from a government-sponsored study, adding a triglyceride-lowering drug to cholesterol-fighting statins i. e Tricor, Abbott...
Abbott Laboratories hopes to win the US Food and Drug Administration’s (FDA) approval to launch its new device – MitraClip that has been designed...
International trials of Novartis AG’s blood pressure pill Diovan and diabetes drug Starlix show, which they neither prevent heart attacks, strokes...
A British fertility clinic is holding a raffle this week, with first prize a human egg by way or promoting its ‘baby profiling’ service, it...
Alarmed by the unjustified use of potentially cancer-causing CT scans, the Medicare watchdog and senior radiologists have been prompted to call on...
Increasingly, knee replacements are becoming one of the most common surgeries in America, as painful arthritis wears out the original knee which...
While, the elderly with failing memories often risk getting lost even on familiar streets, a study of Alzheimer’s patients suggests the risk is...
President Barack Obama’s healthcare bill has rallied support from Support from the Catholic Health Association, a group representing Catholic...
The debate over prostate specific antigen (PSA), the most commonly used prostate cancer screening procedure continues to grow, ever since its...
Dealing another blow to parents blaming vaccines for their children’s illness, a special U. S. court ruled Friday, vaccines containing thimerosal...
The US Food and Drug Administration (FDA) said Friday, a boxed warning will be added to Plavix, an $8-billion-a-year anti-clotting drug sold by...
